During the past decade, Samar Rafik Mohamed Amin conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Samar Rafik Mohamed Amin" are "Anesthesia; Adverse Effect" (1 trials), "Newborn Morbidity" (1 trials) and "Postoperative Nausea and Vomiting" (1 trials). Many other conditions were trialed in "Samar Rafik Mohamed Amin" in a lesser frequency.

Most popular intervention types in "Samar Rafik Mohamed Amin" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Midazolam injection" (1 trials) and "anesthesia of emergency cesarean section" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samar Rafik Mohamed Amin" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Samar Rafik Mohamed Amin". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Samar Rafik Mohamed Amin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samar Rafik Mohamed Amin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".